In January members of the Association, along with Dr. Torsten Baehner, head physician of the Anaesthesia and IC unit at St. Nikolaus-Stift Hospital, displayed the trolley for Ulrich Sielaff, member of the board at LTS.
At the meeting of the LTS Supervisory Board on April 23rd 2018, Prof. Dr. Norbert Loos resigned as Chairman of the Supervisory Board of the LTS AG. Subsequently, the LTS AG Supervisory Board elected Prof. Dr. Christof Hettich as its new Chairman.
Dr. Tim G. Schlange, member of the LTS management board and CMO of LTS, will present at the J.P. Morgan 36th Annual Healthcare Conference 2018 to be held January 8-11th, 2018 at the Westin St. Francis Hotel in San Francisco, CA.
About 10 % of all pharmaceuticals worldwide are suspected to be counterfeited. This may have led to the death of possibly up to 70.000 patients using tuberculosis- and malaria remedies alone, the safety of pharmaceuticals patients had fatally relied upon. LTS supports the global battle against counterfeiting of pharmaceuticals.
With locations in Andernach, West Caldwell and Shanghai, LTS is at home on three continents – for efficient communication, quick access to the market and personal, partnership-based cooperation with our customers and partners.